REVOLAX® Sub-Q with Lidocaine
REVOLAX® Sub-Q with Lidocaine is the highest-density dermal filler within the REVOLAX® range, formulated to provide deep structural support and significant facial volumisation. Its highly cohesive cross-linked hyaluronic acid gel is designed for advanced facial sculpting, delivering exceptional projection and long-lasting contour enhancement.
Developed for deep tissue implantation, REVOLAX® Sub-Q is ideal for patients requiring substantial volume restoration and definition of facial architecture.
Technology & Composition
- Cross-linked hyaluronic acid: 24 mg/mL
- Lidocaine: 0.3%
- Non-animal, biotechnologically produced hyaluronic acid.
- Highly cohesive monophasic gel.
- Advanced cross-linking technology.
- Sterile, biodegradable and fully resorbable injectable gel.
Packaging
Contents:
- 1 pre-filled syringe of 1.1 mL.
- 2 sterile needles.
Indications & Treatment Areas
REVOLAX® Sub-Q is indicated for deep facial augmentation and contour restoration.
Suitable for:
- Chin projection.
- Jawline enhancement.
- Cheek augmentation.
- Facial contouring.
- Severe volume loss.
- Structural facial reshaping.
Recommended treatment areas:
- Chin.
- Jawline.
- Cheeks.
- Facial contours.
Clinical Benefits
- Provides maximum structural support.
- Restores significant facial volume.
- Defines facial contours.
- High projection capacity.
- Excellent tissue stability.
- Long-lasting volumising effect.
Treatment Protocol
REVOLAX® Sub-Q should only be administered by qualified healthcare professionals experienced in advanced facial contouring procedures.
Treatment technique and injection depth should always be determined according to facial anatomy and the desired aesthetic outcome.
Duration of Results
Results generally last 12–18 months, depending on the treatment area, patient metabolism, and injection technique.
Manufacturer & Regulatory Information
Manufacturer: Across Co., Ltd. (South Korea)
- CE Marked Class III Medical Device
- Manufactured under ISO 13485 Quality Management System
- Compliant with Regulation (EU) 2017/745 (MDR)
- Authorised for distribution by AEMPS in Spain and throughout the European Union
For Professional Use Only:
As a trusted distributor in the field of aesthetic medicine, Aesthisave® emphasizes that all our products are intended exclusively for professional use.
These treatments must only be performed by qualified and appropriately trained healthcare professionals, ensuring the highest standards of patient safety and clinical care.
















